Rekha Parameswaran

1.5k total citations
33 papers, 1000 citations indexed

About

Rekha Parameswaran is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rekha Parameswaran has authored 33 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Internal Medicine and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rekha Parameswaran's work include Venous Thromboembolism Diagnosis and Management (14 papers), Platelet Disorders and Treatments (10 papers) and Blood groups and transfusion (6 papers). Rekha Parameswaran is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (14 papers), Platelet Disorders and Treatments (10 papers) and Blood groups and transfusion (6 papers). Rekha Parameswaran collaborates with scholars based in United States, United Kingdom and Hong Kong. Rekha Parameswaran's co-authors include Gerald A. Soff, Hani Hassoun, Russell Moore, Simon Mantha, Nelly G. Adel, Darren R. Feldman, Elyn Riedel, Manisha Bhutani, Amy D. Shapiro and Craig M. Kessler and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Rekha Parameswaran

33 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rekha Parameswaran United States 15 426 422 353 190 141 33 1000
Simon Mantha United States 17 414 1.0× 532 1.3× 473 1.3× 120 0.6× 116 0.8× 57 1.1k
J.F. Timp Netherlands 8 244 0.6× 803 1.9× 509 1.4× 126 0.7× 196 1.4× 15 1.0k
Oliver Königsbrügge Austria 20 174 0.4× 643 1.5× 549 1.6× 250 1.3× 137 1.0× 52 1.2k
Martha Louzada Canada 13 308 0.7× 511 1.2× 368 1.0× 155 0.8× 225 1.6× 78 801
Darko Antić Serbia 14 297 0.7× 273 0.6× 151 0.4× 170 0.9× 81 0.6× 96 823
Frits I. Mulder Netherlands 12 138 0.3× 805 1.9× 523 1.5× 159 0.8× 272 1.9× 31 1.0k
Anthonie W.A. Lensing Netherlands 11 287 0.7× 805 1.9× 476 1.3× 118 0.6× 178 1.3× 14 1.0k
Graham J. Caine United Kingdom 10 145 0.3× 331 0.8× 296 0.8× 213 1.1× 60 0.4× 12 852
Orly Leiva United States 16 216 0.5× 203 0.5× 254 0.7× 120 0.6× 35 0.2× 70 906
Moon Ju Jang South Korea 17 149 0.3× 349 0.8× 195 0.6× 95 0.5× 59 0.4× 40 962

Countries citing papers authored by Rekha Parameswaran

Since Specialization
Citations

This map shows the geographic impact of Rekha Parameswaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rekha Parameswaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rekha Parameswaran more than expected).

Fields of papers citing papers by Rekha Parameswaran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rekha Parameswaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rekha Parameswaran. The network helps show where Rekha Parameswaran may publish in the future.

Co-authorship network of co-authors of Rekha Parameswaran

This figure shows the co-authorship network connecting the top 25 collaborators of Rekha Parameswaran. A scholar is included among the top collaborators of Rekha Parameswaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rekha Parameswaran. Rekha Parameswaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilbert, Leah, et al.. (2022). Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use. Research and Practice in Thrombosis and Haemostasis. 6(3). e12701–e12701. 10 indexed citations
2.
Derkach, Andriy, et al.. (2022). Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer. Haematologica. 108(1). 161–170. 2 indexed citations
3.
Zhang, Allen W., Sejal Morjaria, Anna Kaltsas, et al.. (2021). The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection. Clinical Infectious Diseases. 74(4). 567–574. 24 indexed citations
4.
Soff, Gerald A., Yimei Miao, Jodi V. Mones, et al.. (2019). Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia. Journal of Clinical Oncology. 37(31). 2892–2898. 63 indexed citations
5.
Mantha, Simon, Yimei Miao, Jonathan Wills, Rekha Parameswaran, & Gerald A. Soff. (2017). Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study. Journal of Thrombosis and Thrombolysis. 43(4). 514–518. 58 indexed citations
6.
Soff, Gerald A., Yimei Miao, Sean M. Devlin, et al.. (2017). Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial. Blood. 130. 289–289. 5 indexed citations
7.
Coombs, Catherine C., Deborah Kuk, Sean M. Devlin, et al.. (2017). Outcomes after inferior vena cava filter placement in cancer patients diagnosed with pulmonary embolism: risk for recurrent venous thromboembolism. Journal of Thrombosis and Thrombolysis. 44(4). 489–493. 14 indexed citations
8.
Cybulska, Paulina, Cheryl Goss, William P. Tew, Rekha Parameswaran, & Yukio Sonoda. (2017). Indications for and complications of transfusion and the management of gynecologic malignancies. Gynecologic Oncology. 146(2). 416–426. 20 indexed citations
9.
Mantha, Simon, Yimei Miao, Debra Sarasohn, et al.. (2015). Safe and Effective Use of Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolic Disease: A Quality Improvement Initiative. Blood. 126(23). 431–431. 2 indexed citations
10.
Parameswaran, Rekha, Matthew A. Lunning, Simon Mantha, et al.. (2014). Romiplostim for management of chemotherapy-induced thrombocytopenia. Supportive Care in Cancer. 22(5). 1217–1222. 58 indexed citations
11.
Sandadi, Samith, Stephen Lee, Ginger J. Gardner, et al.. (2012). Incidence of Venous Thromboembolism After Minimally Invasive Surgery in Patients With Newly Diagnosed Endometrial Cancer. Obstetrics and Gynecology. 120(5). 1077–1083. 42 indexed citations
12.
Parameswaran, Rekha & Gerald A. Soff. (2011). Romiplostim in a Case Series of Chemotherapy-Induced Thrombocytopenia. Blood. 118(21). 1170–1170. 3 indexed citations
13.
Kelesidis, Theodoros, et al.. (2010). Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report. Journal of Medical Case Reports. 4(1). 231–231. 3 indexed citations
14.
15.
Parameswaran, Rekha, et al.. (2006). An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agents. Haemophilia. 12(s6). 54–61. 18 indexed citations
16.
17.
Gupta, Vikas, U. M. Hegde, Rekha Parameswaran, & Adrian C. Newland. (2000). Multiple myeloma and immune thrombocytopenia. Clinical & Laboratory Haematology. 22(4). 239–242. 21 indexed citations
18.
Parameswaran, Rekha, et al.. (2000). Spontaneous intracranial bleeding in two patients with congenital afibrinogenaemia and the role of replacement therapy. Haemophilia. 6(6). 705–708. 28 indexed citations
19.
Parameswaran, Rekha, et al.. (2000). CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma. British Journal of Haematology. 109(3). 571–575. 7 indexed citations
20.
Parameswaran, Rekha, et al.. (1971). Effects of hypoxia, reoxygenation, and temperature on cat papillary muscle. American Journal of Physiology-Legacy Content. 220(5). 1289–1293. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Mantha Breakdown of academic impact, for papers by J.F. Timp Breakdown of academic impact, for papers by Oliver Königsbrügge Breakdown of academic impact, for papers by Martha Louzada Breakdown of academic impact, for papers by Darko Antić Breakdown of academic impact, for papers by Frits I. Mulder Breakdown of academic impact, for papers by Anthonie W.A. Lensing Breakdown of academic impact, for papers by Graham J. Caine Breakdown of academic impact, for papers by Orly Leiva Breakdown of academic impact, for papers by Moon Ju Jang
Rankless by CCL
2026